In late June, New York Proton Center colleagues shared their research and expertise at the 60th Particle Therapy Co-Operative Group (PTCOG) Conference in Miami, Florida. This annual event, the largest proton therapy meeting in the world, brings together an audience of more than 1,000 investigators to connect, educate and collaborate on groundbreaking research that will advance the understanding of proton therapy in cancer care.
Given the increasing number of proton centers worldwide, the impactful clinical trials and life-changing research – much of it led by NYPC – discussed at PTCOG 60 are helping to ensure patients receive state-of-the-art cancer care. NYPC had the broadest representation of any institution at the meeting, with radiation oncologists, physicists, dosimetrists, and radiation therapists giving lectures and sharing their experience working at the busiest proton center in the world.
Our team presented their novel research in an incredible 26 oral presentations, scientific sessions and posters, with a brief look at the expansive topics below:
- Numerous sessions on our FLASH therapy research, including specific applications to the treatment of lung and head and neck cancers, and the physics of proton beam performance at ultra-high dose rates.
- New consensus recommendations for treating spinal tumors, anorectal cancers, and thymic tumors with proton therapy.
- Results of a study demonstrating that proton therapy reduces the risk of toxicities in radiation therapy for gynecological cancers.
- Findings of a study (Proton Collaborative Group PCG 001-09)on treatment of recurrent prostate cancer with proton therapy.
- Evaluation of treatment planning model for advanced nasopharynx cancer.
- And much more…
We are grateful to all the experts from around the world who presented their life-changing research at PTCOG, and we are proud to be a part of and lead many of these important discussions that will benefit countless lives.
We look forward to sharing more of our research at PTCOG 61 next year in Madrid!
